Hot Flasher

Hot Flasher
  • 5.0 (2)
  • Sexuality
  • Daily

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

  1. 13h ago

    The Brain, the Ultrasound, and the Herb You've Never Heard Of

    This episode covers three pieces of ovarian health research that landed this week — an ultrasound scoring system that may get better at flagging which ovarian masses are actually dangerous, a rare ovarian cancer case with a survival outcome that's genuinely worth knowing about, and an animal study on a plant compound that improved memory in rats with surgically induced menopause. Nykki breaks down what each one actually means, what the limitations are, and where the real questions live. Key Takeaways: • A modified ultrasound scoring system called O-RADS, now integrated with a malignancy risk calculator, may help doctors better sort low-risk from high-risk ovarian masses — reducing unnecessary surgeries and missed cancers • A 2026 case report documents long-term survival in FIGO stage IVB small cell carcinoma of the ovary, pulmonary type — one of the deadliest ovarian cancers — following complete tumor removal and a second round of platinum chemotherapy • Small cell carcinoma of the ovary, pulmonary type (SCCOHT is a different subtype — this one behaves like lung's small cell cancer) is so rare that individual case reports still genuinely move the needle on what doctors understand about treatment • A rat study found that flavonoids from the skullcap plant improved memory in animals whose ovaries had been removed — but this is very early-stage research in animals, not humans, and the jump from rat brain to your brain is a long one • Animal studies on estrogen loss and cognitive function are useful for understanding mechanisms, but have a poor track record of translating directly into human treatments — worth watching, not worth supplementing based on Sources & References: • Long-term survival in stage IVB small cell ovarian carcinoma after cytoreduction and platinum re-challenge (https://pubmed.ncbi.nlm.nih.gov/42973516/) - PubMed • Modified O-RADS ultrasound framework with malignancy risk algorithm for ovarian carcinoma detection (https://pubmed.ncbi.nlm.nih.gov/42973469/) - PubMed • Skullcap flavonoids and memory impairment in ovariectomized rats: a bioinformatics-guided study (https://pubmed.ncbi.nlm.nih.gov/42973365/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-11-03-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  2. 1d ago

    Calories, Bones, and a Rare Diagnosis You Should Know About

    Today's episode covers three new papers from PubMed: a study protocol asking whether caloric restriction benefits depend on sex hormones, a rare case of vulvar cancer in a postmenopausal woman worth knowing about, and a molecular study on resveratrol and bone loss that sounds more promising in a lab than it is in your supplement drawer. Key Takeaways: • The GendAge study is designed to test whether the health benefits of caloric restriction differ by sex and hormone status — a question that has largely been ignored in prior research, most of which was done in men or male animals. • Benefits like improved metabolism and longevity markers from caloric restriction may be partially driven by — or dependent on — sex hormones, meaning the picture for postmenopausal women could look very different from what current guidelines assume. • Vulvar dermatofibrosarcoma protuberans (DFSP) is an extremely rare soft-tissue cancer that can appear on the vulva in postmenopausal women; the case report highlights that unusual lumps or growths in the vulvar area deserve prompt evaluation, not watching and waiting. • The resveratrol-bone study is a molecular mechanisms paper — it explains a possible biological pathway, not a clinical result. No human trial data shows resveratrol meaningfully prevents bone loss in postmenopausal women at the doses found in supplements. • When you see a supplement marketed on "molecular pathway" research, that's a red flag for overclaiming — pathways found in cell or animal studies frequently do not survive contact with the complexity of a human body. Sources & References: • GendAge Weight Loss Study: Sex hormones and caloric restriction by age and sex (https://pubmed.ncbi.nlm.nih.gov/42969100/) - PubMed • Vulvar dermatofibrosarcoma protuberans in a postmenopausal woman: case report and treatment (https://pubmed.ncbi.nlm.nih.gov/42968853/) - PubMed • Resveratrol and bone metabolism: SIRT1 pathways and therapeutic implications (https://pubmed.ncbi.nlm.nih.gov/42968626/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-11-02-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  3. 4d ago

    Bone Health, Bleeding Surprises, and What Rhodiola Actually Does

    This episode covers three new studies: two looking at herbal compounds for bone loss in rat models, and one large cohort study on SGLT2 inhibitor diabetes drugs and postmenopausal bleeding risk. Nykki breaks down what the science actually shows, what stage of research each finding is at, and which one is actually ready to matter to your doctor. Key Takeaways: • Two herbal compounds — Bushen Huoxue decoction and salidroside (from rhodiola root) — show early promise for bone protection in rat studies, but neither has been tested in humans yet. Rat studies are a starting point, not a destination. • SGLT2 inhibitors, a class of diabetes and heart-failure drugs, were associated with a lower rate of postmenopausal bleeding compared to another diabetes drug class in a large real-world cohort study — an unexpected finding that warrants attention. • Postmenopausal bleeding always needs a doctor's evaluation. It can signal something serious, and no medication finding changes that rule. • The NF-κB pathway targeted in the Bushen Huoxue study is a real and well-established driver of bone breakdown — the biology isn't made up, the human evidence just doesn't exist yet. • Salidroside is already sold in supplements, often as part of rhodiola extracts. The gap between "works in a rat" and "works in a postmenopausal woman at a safe dose" is enormous and currently unbridged. Sources & References: • Bushen Huoxue decoction suppresses bone loss in ovariectomized rats via sirtuin 1 and NF-κB pathways (https://pubmed.ncbi.nlm.nih.gov/42958664/) - PubMed • SGLT2 inhibitors and risk of postmenopausal bleeding: active-comparator cohort study (https://pubmed.ncbi.nlm.nih.gov/42957436/) - PubMed • Salidroside attenuates ovariectomy-induced bone loss through HSPA5 and stress-response signaling (https://pubmed.ncbi.nlm.nih.gov/42957108/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-10-30-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  4. 5d ago

    Bladder, Brain, and the Bodies Medicine Keeps Missing

    This episode covers three research items: what hormonal treatment actually does for bladder symptoms in midlife, why GLP-1 drugs like Ozempic may affect women's Alzheimer's risk differently than men's, and a rare but frequently missed uterine condition that causes years of serious pelvic pain before anyone figures out what it is. Key Takeaways: • Hormonal treatment — including both systemic HRT and local vaginal estrogen — shows real benefit for some lower urinary tract symptoms in midlife, but not all of them respond equally, and the evidence is stronger for some symptoms than others. • GLP-1 signaling works differently in female and male brains, and a new narrative review argues this is directly relevant to Alzheimer's disease risk — which already affects women disproportionately. • Accessory cavitating uterine malformations (ACUMs) are a structural uterine abnormality that can cause severe, ongoing pelvic pain and are frequently misdiagnosed or missed entirely for years. • The ACUM paper covers women across all age groups, meaning this is not just a young-woman problem — it can persist into perimenopause and beyond without a correct diagnosis. • The GLP-1 review is a narrative review, not a clinical trial — it synthesizes existing research and points toward questions that still need answering, not conclusions you can act on yet. Sources & References: • Hormonal treatment and lower urinary tract symptoms in midlife women (https://pubmed.ncbi.nlm.nih.gov/42952301/) - PubMed • Sex differences in GLP-1 signaling and Alzheimer's disease risk (https://pubmed.ncbi.nlm.nih.gov/42952261/) - PubMed • Accessory cavitating uterine masses and chronic pelvic pain across all ages (https://pubmed.ncbi.nlm.nih.gov/42952163/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-10-29-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  5. 6d ago

    Your Brain, Your Clock, Your Habits — Three Studies Worth Knowing

    Three new papers landed this week touching hormone therapy, brain aging, and lifestyle habits in perimenopause. Nykki breaks down what the Alzheimer's-HRT connection actually looks like in the current evidence, what "epigenetic age" means for real women, and why most perimenopausal women's health behaviors fall into one of three distinct clusters — and why that matters for how we talk about lifestyle advice. Key Takeaways: • The link between HRT and lower Alzheimer's risk is real in some studies, but timing is everything — starting hormone therapy early in perimenopause appears more protective than starting years after menopause. • "Epigenetic age" is a way of measuring how old your cells act, not just how old you are. Early research suggests estrogen therapy may slow that biological clock, especially in women with stable blood sugar. • A 2026 study using the COM-B behavioral model found perimenopausal women cluster into three distinct health-behavior profiles — and the majority fall into groups with significant gaps in either physical activity or stress management, not both. • Narrative reviews summarize existing research rather than generating new data — they're useful for seeing the landscape, but they don't settle questions the way a large clinical trial does. • The Alzheimer's-HRT research is promising enough to ask your doctor about, but not definitive enough to treat as a proven benefit yet. Sources & References: • Health-promoting behaviors in perimenopausal women: a latent profile analysis (https://pubmed.ncbi.nlm.nih.gov/42947229/) - PubMed • HRT through the lens of the epigenetic clock: estrogen, blood sugar, and lifespan (https://pubmed.ncbi.nlm.nih.gov/42947173/) - PubMed • Menopause and Alzheimer's disease: can HRT modify the risk? (https://pubmed.ncbi.nlm.nih.gov/42947097/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-10-28-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  6. Oct 27

    Bones, Migraines, and the Weird Liver Finding You've Never Heard Of

    This episode covers three new research items: a rare case of endometriosis showing up as a liver cyst after menopause, a thorough review on preventing and managing bone thinning across a woman's lifetime, and a large Korean cohort study on how menopause changes the heart-disease risk that comes with migraine. Nykki unpacks what the evidence actually says — and where it still has gaps. Key Takeaways: • Endometriosis doesn't always disappear after menopause — in rare cases, tissue deposits in unusual locations like the liver can keep growing, especially if estrogen replacement is involved. • Bone thinning accelerates fastest in the first few years after menopause, which makes the perimenopausal window a critical time to build protective habits — strength training and adequate protein matter here. • Women who have migraines appear to carry a higher risk of heart disease than women who don't — and that gap widens noticeably after menopause, according to a nationwide Korean study of over 4 million women. • The migraine-heart connection is not fully understood, and the Korean study is observational — it shows a pattern, not a proven cause. • Bone density scans (DEXA scans) are routinely recommended starting at age 65, but women with early menopause or additional risk factors should talk to their doctor about scanning earlier. Sources & References: • Serial CT findings of a giant hepatic endometriotic cyst in a postmenopausal woman (https://pubmed.ncbi.nlm.nih.gov/42935271/) - PubMed • Menopausal osteoporosis: a life-course approach to prevention and management (https://pubmed.ncbi.nlm.nih.gov/42935107/) - PubMed • Menopausal status modifies the association between migraine and cardiovascular disease risk: a nationwide cohort study (https://pubmed.ncbi.nlm.nih.gov/42934511/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-10-27-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  7. Oct 26

    Sex, Dry Eyes, and Your Heart — The Menopause Stuff No One Connects

    A new study finds that when middle-aged women stop having sex, menopause isn't usually the reason — and the actual drivers matter for how we talk about midlife sexuality. Plus: dry eyes are a real menopause symptom that researchers now want formally built into clinical care, and a new framework reframes women's heart health across four life stages with menopause right in the middle of it. Key Takeaways: • When researchers asked middle-aged women why they'd stopped having sex, the most common reasons were partner-related factors and mental health — not menopause symptoms like vaginal dryness or low hormone levels. • Dry eye disease is more common and more severe after menopause, likely driven by the same hormonal shifts that cause other symptoms — and researchers are now calling for it to be treated as a standard part of menopause care, not a side issue for the eye doctor. • A new clinical framework published in 2026 breaks women's heart health into four distinct life stages: early life, reproductive years, the menopause transition, and older age — with the menopause transition identified as a key window where risk can change fast. • The new heart framework is pushing doctors to look at pregnancy complications, early periods, and menopause timing as cardiac warning signs — not just cholesterol and blood pressure. • Estrogen's protective effect on the heart is real, and the menopause transition is now being treated by some cardiologists as a moment to pay closer attention — not wait until symptoms show up. Sources & References: • Researchers asked middle-aged women why they stopped having sex — it wasn't menopause (https://news.google.com/rss/articles/CBMilAFBVV95cUxPTjF4RWliZ08wT2I0U0Q5TEJnRElHdzI4emptcTNsSkI2M2pjV1J3ME0taUN2RW9jaEJrbm4xZFRJWmphaGg2X2pxc0habzloMWwxcTJ5RkI4MGVIVkUyNmM3M3JOMTB1YllxUjlTLVg1SzMtY1BSMDRjSHhobURZb1RxUUFoTlR3ME51U3kwVE1HSE00?oc=5) - Yahoo News • Researchers urge adding dry eye treatment to menopause care (https://news.google.com/rss/articles/CBMiqwFBVV95cUxQb2J5amE3ajE0b29ldklONmJ6U01FdjRNaEpIZ0hvSmhrN1VVTTBMRnpsNkR4cndOd0tnakptUXkzYlhxWENBTVhKWFZJdXN3UDgxbnk0U1g0Sm9hUnZYLVI4bTU3NmlnTzV3cC1OZzJoZFlfcWhaUzFGNVdNRU02b2RsRENyWkJpQU5IblpDcllnc3d2OWhDcG1NSy1paDBreVM4M0dKRWNhSFk?oc=5) - Medscape • The four stages of women's heart health: experts present new framework (https://www.statnews.com/2026/10/26/heart-health-women-four-life-stages-qa-sadiya-khan/) - STAT News Listen with full show notes: https://hotflasher.com/episodes/2026-10-26-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  8. Oct 23

    Your Gut, Your Bones, and Why Being Well-Fed Is a Radical Act

    This episode covers three wellness angles worth taking into the weekend: why estrogen loss reshapes your gut microbiome and what to do about it, why bone loss is so easy to miss until something breaks, and why a nutritionist's argument that eating enough is a "radical act" is more than just a catchy phrase. Key Takeaways: • Estrogen plays a direct role in gut bacteria balance. When it drops in perimenopause, bloating, new constipation, and IBS-like symptoms can follow — and those symptoms are often dismissed as stress rather than recognized as hormonal. • Bone loss from estrogen decline can be completely silent. A woman can have significant bone thinning with zero pain and no symptoms, and a minor slip — not a real fall — can cause a fracture. • A DEXA scan measures bone density, but it doesn't tell the whole story. A full conversation with a doctor about your personal risk factors matters as much as the number on the scan. • Fermented foods (like yogurt, kefir, kimchi) show early promise for supporting gut bacteria during menopause, though the research is still developing. • The pressure on midlife women to shrink — eat less, weigh less, take up less space — runs directly counter to what the body actually needs at this stage, including adequate protein and enough calories to support muscle and bone health. Sources & References: • Are your bones brittle? If they were, how would you know? (https://www.theguardian.com/commentisfree/2026/oct/20/brittle-bones-osteoporosis-diagnosis-treatment-health) - The Guardian • Why Being Well-Fed Is a Radical Act with Lisa Kilgour (https://notyourmothersmenopause.libsyn.com/ep-241-undieting-why-being-well-fed-is-a-radical-act) - Not Your Mother's Menopause Listen with full show notes: https://hotflasher.com/episodes/2026-10-23-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

See All (159)

Ratings & Reviews

5
out of 5
2 Ratings

About

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

Information

  • Creator
    Hot Flasher
  • Years Active
    2026
  • Episodes
    159
  • Rating
    Clean
  • Show Website
    Hot Flasher